It has been a few years since my post on ‘Twitter for urologists’ was published in Urology News [1]. Given the continued rise of the platform, I thought it was time to revisit and expand on Twitter’s functionality. In this...
At The Urology Foundation (TUF) we are acutely aware that the attention of our colleagues in the urology profession are rightly elsewhere at the moment. I would like to thank all urologists, urology nurses and urology researchers for the ...
BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, and distribution partner for PrecisionPoint™, the...
BPH Focus 2023 To skip directly to features, click the links below: Welcome from the editor- by Feras Al Jaafari Needs must, is it time for a major rethink for men with symptomatic BPH? An update from the GIRFT Academy-...
For Part 1 of this topic is available here. The major limitations of the transrectal ultrasound (TRUS) guided prostate biopsy (PBx) protocols are the risk of profound sepsis and the risk of persistently significant false negative rates, related to the...
Introduction Urolithiasis is an increasing healthcare problem, with an estimated lifetime prevalence of up to 15% [1]. The number of interventions undertaken for stone disease has increased dramatically over recent years, particularly with respect to ureteroscopy and percutaneous nephrolithotomy (PCNL)...
With urethral catheterisation volumes currently considerably increased, we are pleased to be able to announce that NHS Supply Chain is now listing the...
15:00-16:30 CET (Europe)
09:00-10:30 EST (US & Canada Eastern)
Presented by Dr. Dick Janssen.
This online webinar explains Urodynamic investigations and curve interpretation in order to improve the performance of examinations in daily practice.
The diagnostic superiority of multiparametric magnetic resonance imaging (mpMRI) prior to targeted and systematic prostate biopsy over systematic transrectal ultrasound-guided (TRUS) biopsy alone in the detection of clinically significant prostate cancer (csPCa) has been proven by multiple level 1 studies...
1 July 2017
| Gidon Ellis, Susie Longhorn, Vimoshan Arumuham, Rebecca Dale, Sian Allen, Simon Choong, Shabbir Moochhala, Chris Laing, Daron Smith
|
Endourology and Stones
The incidence and prevalence of kidney stones is increasing [1,2]. Significant recurrence rates are noted with 14% of patients experiencing a further episode at one year, 35% at five years, and 52% at 10 years [3]. Over 10% of stone...
The SIU is set to host its 39th Congress in the historic capital of Europe: Athens, Greece! Join us 17-20 October for expert coverage of the most pertinent issues in urology. Plan to arrive early and participate in additional programming...
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in...